Kazi Tasnuva Alam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazi Tasnuva Alam has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Tanvir Ahmed
North South University
6 shared publications - Zarin Tasnim Tisha
University of Surrey
3 shared publications
Latest Publications
- 2 July 2026
- Published by Springer Nature
- p. 139-195
Diagnostic Nanoprobes and Imaging Agents
- 2 July 2026
- Published by Springer Nature
- p. 197-249
Nanomaterials for Regenerative Medicine
- 29 January 2026
- Published by Springer Nature
- p. 177-214
Effect of Original Reinforcement and Surface Functionalization on Properties
- 29 January 2026
- Published by Springer Nature
- p. 177-214
Effect of Original Reinforcement and Surface Functionalization on Properties
- 22 January 2026
- Published by Springer Nature
- p. 149-179
miRNA Modulation of Cancer Therapeutic Resistance Due to Failed Autophagy and Cancer Stemness
- 22 January 2026
- Published by Springer Nature
- p. 149-179
miRNA Modulation of Cancer Therapeutic Resistance Due to Failed Autophagy and Cancer Stemness
- Open Access
- 19 March 2025
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 4 (1)
Cardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Cardiac tissue engineering presents a viable strategy for the targeted therapy of myocardial infarction (MI), overcoming the limitations of existing therapies in cardiac repair and regeneration. This review explores the potential of stimuli‐responsive biomaterials that engage with the cardiac environment by reacting to various environmental stimuli including pH, temperature, enzymes, ultrasound, and reactive oxygen species. These materials enable precise drug delivery, modulate cellular responses, and enhance tissue regeneration. Biomaterials such as hydrogels, polymers, chitosan, collagen, and alginate improve the accuracy and effectiveness of targeted and localized delivery of drugs, stem cells, and growth factors, thus improving the precision and efficacy of treatments. The review looks at the ability of these biomaterials to mimic the complex biochemical and mechanical cues of a healthy myocardium. The challenges and prospects of clinical applications for stimuli‐responsive biomaterials are discussed, highlighting their transformative potential in targeted cardiac therapy while improving outcomes for patients with MI.
- 19 March 2025
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 4 (1)
Open AccessCardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction
Cardiac tissue engineering presents a viable strategy for the targeted therapy of myocardial infarction (MI), overcoming the limitations of existing therapies in cardiac repair and regeneration. This review explores the potential of stimuli‐responsive biomaterials that engage with the cardiac environment by reacting to various environmental stimuli including pH, temperature, enzymes, ultrasound, and reactive oxygen species. These materials enable precise drug delivery, modulate cellular responses, and enhance tissue regeneration. Biomaterials such as hydrogels, polymers, chitosan, collagen, and alginate improve the accuracy and effectiveness of targeted and localized delivery of drugs, stem cells, and growth factors, thus improving the precision and efficacy of treatments. The review looks at the ability of these biomaterials to mimic the complex biochemical and mechanical cues of a healthy myocardium. The challenges and prospects of clinical applications for stimuli‐responsive biomaterials are discussed, highlighting their transformative potential in targeted cardiac therapy while improving outcomes for patients with MI.
- 21 February 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (3) , 1-28
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
The prognosis for patients with glioblastoma multiforme (GBM), an aggressive and deadly brain tumor, is poor due to the limited therapeutic options availab
- 21 February 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (3) , 1-28
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
The prognosis for patients with glioblastoma multiforme (GBM), an aggressive and deadly brain tumor, is poor due to the limited therapeutic options availab